Clinical Trials

Clinical Trials

The Department of Urology has over 20 years of experience in human-studies research and conducting clinical trials in a number of disease areas. Approximately 150 trials have been completed with enrollment on target. These trials have included investigator-initiated and industry trials.  We have worked with most of the major pharmaceutical companies in all phases of the clinical trial spectrum. Sponsor satisfaction with our team is consistently high, frequently resulting in subsequent trials with the same sponsor(s).

Below is a list of our active clinical trials.

Currently Enrolling Patients

Altor - QUILT-3.032

A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BHG) in Combination with ALT-803 in Patients with BCG Unresponsive High-Grade Non-Muscle Invasive Bladder Cancer – CA-ALT-803-01-16.

Learn more about this trial

PI: Sam S. Chang, MD

CxBladder

Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design.

Learn more about this trial

PI: Kristen Scarpato, MD

CISTO Study – NMIBC

The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer.

Learn more about this trial

PI: Kristen Scarpato, MD

Talapro-2 (Pfizer)

Newly diagnosed mCRPC (no prior systemic therapy in this state) to receive enza +/- talazoparib, primary outcome rPFS, secondary outcome OS)

Learn more about this trial

PI: Kelvin Moses, MD

Janssen

Neo-adjuvant and adjuvant apalutamide/placebo plus ADT in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy

Learn more about this study

PI: Kelvin Moses, MD

Medtronic Registry Study

Medtronic Product Surveillance Registry (PSR).

Learn more about this study

PI: Melissa Kaufman, MD

Cook Myosite

CELLEBRATE:  An Adaptive, Two-Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence.

Learn more about this study

PI: Roger Dmochowski, MD

Botox Injection Antibiotic Study

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection:  A Non-Inferiority Trial.

Learn more about this trial

PI: Melissa Kaufman, MD

MDx Health – PRIORITY Study

Prospective Validation of Prostate Biomarkers for Repeat Biopsy:  The PRIORITY Study.

Learn more about this study

PI: Sam S. Chang, MD

Ureteral Stent Trial

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial. The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.

Learn more about this trial

PI: Ryan Hsi, MD

Kidney Stone Pain (ENORC)

Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones (ENORC).  The objective of this study is to prospectively determine if the removal of non-obstructing renal calculi can reduce or eliminate participant's pain and/or improve their quality of life.

Learn more about this trial

PI: Ryan Hsi, MD

MOSES Laser (MOLEP)

A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial

Learn more about this trial

PI: Nicole Miller, MD

Struvite Stones Antibiotic

The aim of this research is to determine an effective antibiotic regimen following definitive surgical therapy of kidney stones caused by bacterial infection (struvite stones).

Learn more about this trial

PI: Ryan Hsi, MD; Nicole Miller, MD

EDRN – MRI Study

NCI Early Detection Research Network – EDRN Prostate MRI Biomarker Study and Reference Set.

Learn more about this trial

PI: Dan Barocas, MD

Enrollment Closed, Study In-Progress

Galil Medical

Tracking Renal Tumors After Cryoablation Evaluation (TRACE), Protocol NO CUC10-RNL02-01

Learn more about this study

PI: Duke Herrell, MD

PROSTQA-RP2

Effectiveness of Open and Robotic Prostatectomy: The PROSTQA-RP2 Cohort Study

Learn more about this study

PI: Joseph Smith, MD

PROSPER: Medivation

A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Learn more about this trial

PI: David Penson, MD

EMBARK: Medivation

A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy

Learn more about this trial

PI: David Penson, MD

TRUMPET: ONC-MA-1004

A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States Protocol: ONC-MA-1004

Learn more about this trial

PI: David Penson, MD

Profound-TULSA PRO

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients with localized Prostate Cancer: A Prospective, Single-Arm, Pivotal Clinical Study

Learn more about this trial

PI: David Penson, MD

MDx Health - Hematuria

Multi-institutional study to evaluate DNA methylation markers for detection of primary bladder cancers in urine samples from a cohort of patients with hematuria.

Learn more about this study

PI: Kristen Scarpato, MD

FKD Therapies/Instiladrin

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Learn more about this trial

PI: Kirk Keegan, MD

Taris Biomedical-MIBC

A Multicenter Study Evaluating Safety and Efficacy of TAR-200 in Subjects with Muscle-Invasive Urothelial Carcinoma of The Bladder Who are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who are Unfit for Radical Cystectomy

Learn more about this study

PI: Kirk Keegan, MD

CPI-1205 ProSTAR

ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer

Learn more about this study

PI: Kelvin Moses, MD

Dendreon Active Surveillance

A Randomized Phase 3, Open-Label Trial of Sipuleucel-T Administered to Patients on Active Surveillance for Newly Diagnosed Prostate cancer, Protocol P17-1

Learn more about this trial

PI: Kelvin Moses, MD

MCT Study - MIBC

Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response Among Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy.

Learn more about this trial

PI: Chris Wallis, MD